Wormwood
Best-in-class: Wormwood
A traditional antiparasitic bitter, and the plant behind absinthe. Included with a firm safety note.
Wormwood quick facts
| Suggested dose | Short courses only, as directed. Not for continuous use. |
| How often | Short courses only - never continuous |
| Who it's for | Traditional antiparasitic protocols under guidance. |
The antiparasitic mechanism is real and pharmaceutically validated for malaria. The thujone content is the limit on duration: it is convulsant at sufficient dose, which is why traditional protocols cycle rather than run continuously. Thujone-free extracts exist. Avoid in pregnancy and in seizure disorders. Usually combined with black walnut and clove.
How Wormwood actually works
Artemisinin and related sesquiterpene lactones. Artemisinin's antimalarial mechanism is iron-catalyzed cleavage of its endoperoxide bridge, generating free radicals inside the parasite — a genuinely clever and well-characterized mechanism. Thujone, a separate constituent, is a GABA-A antagonist and is the neurotoxic component.
Where to get Wormwood
Find Wormwood on iHerb →What it is, why it recurs, and where this fits — free to read.
The evidence for Wormwood
Graded by what exists behind each claim.
✅ Clinically validated
- A small randomized trial in Crohn's disease showed steroid-sparing effects. Antiparasitic use in humans is largely traditional rather than trial-supported.
📊 Correlative data
- Long European use as a bitter and an antiparasitic, and the source of absinthe. The observational history is a caution as much as a recommendation: chronic high-dose absinthe consumption in 19th-century Europe was associated with neurological toxicity attributed to thujone, which is why concentrations are now regulated.
🧪 Theoretical / extrapolated benefits
- Related Artemisia species produce artemisinin, which is a genuinely important antimalarial — but A. absinthium is not the artemisinin species, and that conflation drives a lot of the marketing.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What Wormwood actually does
One plant, three unrelated chemistries, and almost every claim made for it belongs to a different one of the three. Artemisia absinthium carries bitter sesquiterpene lactones, of which absinthin is the signature; it carries the monoterpene ketones alpha- and beta-thujone in its essential oil; and it carries flavonoids and phenolic acids that do what flavonoids and phenolic acids do Batiha 2020. The bitter, the neuroactive and the antioxidant fractions are separable, behave differently on heating and in alcohol, and are not present in fixed proportion.
The bitter fraction acts before anything is absorbed. Absinthin is one of the most intensely bitter compounds in the European pharmacopeia and it works on the TAS2R bitter taste receptor family in the mouth and along the gut. Engaging those receptors triggers the cephalic phase of digestion — saliva, gastric acid, bile flow — through a vagal reflex, which is why a bitters dose is measured in drops taken before a meal rather than in grams taken with one. Any effect that arrives within minutes of tasting the thing is this receptor, not a systemic drug action.
Thujone is the part with a real receptor pharmacology, and it is the part nobody wants. Alpha-thujone is a non-competitive antagonist at the GABAA receptor: it blocks the chloride channel rather than competing at the GABA site, so it removes inhibition instead of adding excitation, and the dose-response for convulsions follows directly from that. The same work showed the way out — rapid cytochrome P450 hydroxylation to 7-hydroxy-alpha-thujone, a metabolite with far less activity, which is why the effect is short-lived and why the toxic dose is a rate question rather than a storage question Höld 2000. Beta-thujone is the weaker isomer, and the ratio of the two is a property of the plant, not of the label.
What the plant does not carry is the molecule most of its marketing is borrowing. Artemisinin is an endoperoxide sesquiterpene lactone whose antimalarial action is iron-catalyzed cleavage of the peroxide bridge inside the parasite. Artemisia annua makes it. Artemisia absinthium makes sesquiterpene lactones that are not endoperoxides, and an endoperoxide bridge is not an optional decoration on that mechanism — it is the mechanism. A page that prints artemisinin next to a picture of wormwood has changed species without telling the reader.
The one human trial reports an immune endpoint, not a parasite one. A controlled clinical trial of a wormwood preparation in Crohn's disease reported suppression of tumor necrosis factor alpha and accelerated healing Krebs 2010. TNF is the target of several licensed biologics, so a botanical moving it is worth taking seriously; it is also a completely different claim from killing a helminth, and the trial does not support the second one.
Cell, rodent, human — and where it stops
The chain here runs cell to human on the neurotoxicity and stops at tradition on the antiparasitic use, which is the opposite of how the product is sold.
In the dish and in rodents. Alpha-thujone's block of the GABAA chloride channel was characterized in recombinant receptors and in mice, with the convulsant dose and the P450 detoxification route measured in the same paper Höld 2000. That is a complete mechanism-to-effect chain, and every step of it is about harm.
In people, for benefit, there is one controlled trial and it is in a disease. Krebs and colleagues randomized patients with Crohn's disease to a wormwood preparation or control and reported reduced TNF and improved healing Krebs 2010. The obstacle to transfer is not subtle: the population was people with active inflammatory bowel disease under specialist care, the endpoint was a disease-activity measure, and no part of that generalizes to somebody taking a bitter tincture for a suspected parasite.
The famous human evidence for harm turns out to be a reconstruction, and it has been re-examined. Absinthism — the 19th-century syndrome of hallucination, seizure and degeneration attributed to thujone in absinthe — has been analyzed as a fictitious entity, with the chronic alcoholism of the drinkers a sufficient explanation and the thujone concentrations in period absinthe far below what the story requires Padosch 2006. The review that followed put both sides on the record: the plant has documented neurotoxic potential and documented neuroprotective activity depending on preparation and dose Lachenmeier 2010. Both of those matter here. The historical scare was overstated; the acute risk from concentrated essential oil was not.
Where the transfer actually breaks is composition. A toxicological assessment of thujone-containing herbal and botanical products had to reason about exposure from preparations whose thujone content is variable and often undeclared Pelkonen 2013. Dose in this plant is not the mass of herb; it is the mass of herb times a concentration that the label does not carry.
Wormwood — which form, and does it matter
The first form question is which Artemisia, and the answer is not the one the marketing implies. The antimalarial belongs to Artemisia annua. Wormwood is Artemisia absinthium. They are different species with different secondary metabolism, and the conflation is not a rounding error — there is no endoperoxide chemistry in absinthium to do the thing annua is famous for. Anything sold as wormwood on the strength of artemisinin is selling one plant with another plant's evidence.
The second form question is thujone content, and it is genetic before it is anything else. Wormwood accessions from a single country differ measurably in development and in chemical profile, including essential oil composition, which is what intraspecific-variability work is for Kosakowska 2025. Chemotypes exist. That means two products truthfully labeled “Artemisia absinthium herb” can differ severalfold in the constituent that sets the safe duration, and neither label is lying.
The third question is extraction, and it decides almost everything. Thujone is a volatile, poorly water-soluble monoterpene. A water infusion extracts comparatively little of it and plenty of the bitter glycosides; an ethanolic tincture extracts more; a steam-distilled essential oil is a concentrate of exactly the fraction you were trying to avoid. The published poisonings involve essential oil, not tea, and that distinction is a chemistry fact rather than a caution — the pharmacokinetic literature on this plant treats the oil and the aqueous extract as different materials Batiha 2020.
“Thujone-free” is a real category and an unverified claim at the same time. Thujone can be removed, and regulators set numerical limits for thujone in bitter spirits precisely because it can be measured Pelkonen 2013. A dietary supplement is not a bitter spirit and carries no equivalent requirement to declare the number, so “thujone-free” on a capsule is a claim with no assay attached unless the seller publishes one. The question worth asking a vendor is not whether the product is thujone-free but what the certificate of analysis says the thujone content is, in milligrams per gram, and by what method.
And the fourth is that the trial material is a specific preparation. The Crohn's trial used a defined wormwood preparation at a defined dose Krebs 2010. Buying loose herb and steeping it is not that. This is the ordinary situation in botanical medicine and it is worth stating plainly rather than allowing a trial to underwrite an entire shelf.
What would have to be true, and how you would know it was not
1. Predict nothing measurable happens to an infection marker, and check it. If wormwood is being taken for a suspected parasite, the falsifiable version is a stool ova-and-parasite study or a PCR-based gastrointestinal panel before and after a course, plus eosinophil count on a complete blood count. Prediction: eosinophils do not fall and the stool study does not convert, because there is no human trial evidence that this species clears any named parasite Krebs 2010. A documented conversion in a controlled setting would falsify that and would be worth publishing.
2. Predict the inflammatory read-out, in the population where a trial exists. In inflammatory bowel disease under specialist care, the honest endpoints are hs-CRP, fecal calprotectin and the steroid dose — the trial's own logic Krebs 2010. Retest window is 8 to 12 weeks. Prediction: in somebody without inflammatory bowel disease, hs-CRP will not move, because there is no inflammation to suppress.
3. Predict the bitter effect arrives in minutes and the systemic effect does not arrive at all. Taste-receptor-driven digestive changes are fast and dose-independent above a low threshold. If somebody reports that appetite and digestion improved on the first day, that is the prediction succeeding and it says nothing about parasites.
4. Predict a liver and kidney panel stays normal on a short course and is the first thing to move on a long one. Case reports of injury involve essential oil and excessive intake Lachenmeier 2010. Baseline ALT, AST and creatinine, repeat at four weeks if the course is being extended, and treat a rise as a reason to stop rather than a coincidence.
5. The prediction that would embarrass the category. If a commercial wormwood product were assayed and its thujone content came back at zero across a dozen brands, the entire duration caution here would be unnecessary and the page would be wrong. Predict instead that an assay across brands finds a wide spread, because that is what intraspecific chemical variability implies Kosakowska 2025 and because thujone-limit regulation exists for measurable reasons Pelkonen 2013.
What nobody has tested yet
Nobody has assayed the shelf. There is chemical-variability work on wild and cultivated accessions Kosakowska 2025 and there is regulatory toxicology on thujone exposure Pelkonen 2013, and there is no published survey that buys thirty on-market wormwood supplements and reports thujone in milligrams per daily serving. That is one paper. Until it exists, no safe-duration advice for this plant rests on anything but the assumption that the product resembles the material somebody once measured.
Nobody has repeated the Crohn's trial. A controlled trial reporting TNF suppression by a botanical is an unusual result and it has not been replicated at scale Krebs 2010. Whether the active fraction is the bitter lactones, the flavonoids or something else is unresolved, and the trial was not designed to separate them.
Nobody has tested the antiparasitic claim in a person. The traditional use is centuries old and the modern evidence is in vitro and in animals Batiha 2020. A randomized trial in confirmed intestinal helminth infection, with stool PCR as the endpoint, has not been run. It would be a small, cheap, decisive study, and its absence is the reason this section exists rather than a conclusion.
And the historical question is only half settled. The reanalysis that dismantled absinthism Padosch 2006 answered what did not happen. It did not establish a no-effect level for chronic low-dose thujone in humans, and no prospective study ever will, because nobody would approve it.
Wormwood — its own safety story, not its category's
The risk here is a channel blocker with a known convulsant mechanism, which is a different kind of risk from most of this catalog. Alpha-thujone antagonizes the GABAA chloride channel Höld 2000. Anything that removes inhibitory tone lowers the seizure threshold, and that is a pharmacological statement rather than a theoretical caution. It is also why the risk is highest in exactly the people who would not know they were at risk.
The dangerous form is the essential oil and it is sold in the same aisle. Reported neurotoxicity and organ injury cluster around concentrated oil and excessive intake, not around a bitter tincture taken as directed Lachenmeier 2010. Wormwood essential oil is not an oral dosage form, and treating volume as if it were interchangeable across preparations is the specific mistake this plant punishes.
The metabolic route is a cytochrome, which makes the interaction list a rate list. Detoxification runs through P450 hydroxylation Höld 2000, so anything that slows that pathway raises exposure to the parent compound at an unchanged dose. Grapefruit, azole antifungals and several antiretrovirals are the usual suspects for P450 inhibition; the direction of the effect is predictable even where the magnitude has not been measured for this molecule.
Anticonvulsant therapy is the interaction that matters most and it is pharmacodynamic. A GABAA antagonist works against drugs whose whole purpose is to raise inhibitory tone. This will not show up as a changed drug level on a therapeutic drug monitoring test, which is precisely what makes it easy to miss.
Two exclusions that are not negotiable and one that is often forgotten. Pregnancy, because thujone-containing Artemisia preparations are traditionally abortifacient and the regulatory assessments treat them as such Pelkonen 2013. Any seizure history, for the mechanism above. And Asteraceae sensitivity — ragweed, chrysanthemum, daisy — because wormwood belongs to that family and cross-reactivity is a family-level phenomenon, not a species-level one.
What no honest page can give you is a number. There is no established safe daily thujone intake from supplements, because the products do not declare thujone and the variability is real Kosakowska 2025. Short courses are the standard advice because the exposure cannot be computed, not because a threshold is known.
Sources read for this page
- Krebs S. Wormwood (Artemisia absinthium) suppresses tumour necrosis factor alpha and accelerates healing in patients with Crohn's disease - A controlled clinical trial. Phytomedicine 2010 · PMID 19962291
- Höld KM. Alpha-thujone (the active component of absinthe): gamma-aminobutyric acid type A receptor modulation and metabolic detoxification. Proc Natl Acad Sci U S A 2000 · PMID 10725394
- Padosch SA. Absinthism: a fictitious 19th century syndrome with present impact. Subst Abuse Treat Prev Policy 2006 · PMID 16722551
- Lachenmeier DW. Wormwood (Artemisia absinthium L.)--a curious plant with both neurotoxic and neuroprotective properties?. J Ethnopharmacol 2010 · PMID 20542104
- Pelkonen O. Thujone and thujone-containing herbal medicinal and botanical products: toxicological assessment. Regul Toxicol Pharmacol 2013 · PMID 23201408
- Kosakowska O. Intraspecific Variability of Wormwood (Artemisia absinthium L.) Occurring in Poland in Respect of Developmental and Chemical Traits. Molecules 2025 · PMID 40733181
- Batiha GE. Bioactive Compounds, Pharmacological Actions, and Pharmacokinetics of Wormwood (Artemisia absinthium). Antibiotics (Basel) 2020 · PMID 32585887
How you would know if it worked
There is no blood test for this one. That is not a criticism — it is a fact about the effect, and it changes how you should judge it.
- What to watch: Under guidance in Crohn's, the endpoint is the one the small trial used — whether the steroid dose can come down without symptoms returning, which is a decision made with a doctor rather than by how your week went. For traditional antiparasitic use there is no endpoint, because there is no human trial evidence to define one.
- How long before it means anything: Short courses, weeks rather than months, with the ceiling set by thujone and not by dosing logic. Extending a course because nothing has happened yet is the specific mistake this plant punishes, and seizures are the documented risk.
- What will fool you: The artemisinin conflation. A related Artemisia species produces a genuinely important antimalarial and this is not that species, so a lot of the confidence people bring to wormwood is borrowed from a different plant. Bitters also sharpen appetite and ease digestion, which is easy to mistake for something being killed.
Run it one variable at a time. Starting three things in one week means a result you cannot attribute, which is the same as no result.
Wormwood — safety & side effects
- GI upset and, at higher doses, headache and dizziness.
- Thujone is neurotoxic — seizures and kidney injury have been reported with wormwood oil and with excessive intake. Use only thujone-free preparations, and only in short courses.
- Avoid entirely with epilepsy, in pregnancy (abortifacient), and with kidney disease. Allergy in people sensitive to ragweed and daisies.
- One of the few things here where the traditional dose and a harmful dose are close together.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
- When to take it, and what to take it with
- Which form actually absorbs
- Who it's worth it for
- Best-in-class brand pick
- Coach Cam's stacks and notes
- Fasted or with food, and when in the day
- Morning or night, and why that window
- Around training, or deliberately away from it
- What it must not share a window with
Everything above is free and stays free. Skool is where it becomes a plan — Wormwood in an order, with the rest of what you're running.
Unlock in Skool — $10/mo →Bloodwork to run alongside Wormwood
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| Complete Blood Count (CBC) with Differential | Anemia is the commonest sign of a gut absorbing badly |
| Ferritin | Iron is the first thing malabsorption takes |
| Vitamin B12 | The second thing, and the one with permanent consequences |
| hs-CRP (High-Sensitivity C-Reactive Protein) | Separates inflammatory bowel disease from IBS |
The Gut Health & Absorption panel covers these in one order — 11 markers, $208.80 with the discount applied.
Check results you already have → · All 103 markers A–Z
Wormwood — frequently asked questions
What is Wormwood?
A traditional antiparasitic bitter, and the plant behind absinthe. Included with a firm safety note.
What is the suggested dose of Wormwood?
Short courses only, as directed. Not for continuous use. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
Where can I find Wormwood dosing and the full breakdown?
The suggested dose and the full evidence — clinical, correlative and theoretical — are on this page. What's inside Skool is when to take it, which form actually absorbs, the brand worth buying and Coach Cam's stacks.
Where can I buy Wormwood?
Coach Cam sources Wormwood from vetted, top-rated brands on iHerb — use the buy link on this page.
What Wormwood is used for
Wormwood appears under 1 goal in the goal router.
Related Gut & Digestion supplements
Where this goes next
The pages here are the frameworks. The protocols — the dosing, the order to correct things in, the week-by-week schedule and what to retest — are inside Skool.